5JYM
Human P-cadherin EC12 with scFv TSP11 bound
5JYM の概要
| エントリーDOI | 10.2210/pdb5jym/pdb |
| 関連するPDBエントリー | 5JYL |
| 分子名称 | Cadherin-3, Antibody scFv TSP11, CALCIUM ION, ... (4 entities in total) |
| 機能のキーワード | cadherin, cell adhesion, antibody, protein-protein interaction, oxidoreductase, cell adhesion-immune system complex, cell adhesion/immune system |
| 由来する生物種 | Homo sapiens (Human) 詳細 |
| タンパク質・核酸の鎖数 | 4 |
| 化学式量合計 | 101920.83 |
| 構造登録者 | |
| 主引用文献 | Kudo, S.,Caaveiro, J.M.M.,Nagatoishi, S.,Miyafusa, T.,Matsuura, T.,Sudou, Y.,Tsumoto, K. Disruption of cell adhesion by an antibody targeting the cell-adhesive intermediate (X-dimer) of human P-cadherin Sci Rep, 7:39518-39518, 2017 Cited by PubMed Abstract: Human P-cadherin is a cell adhesion protein of the family of classical cadherins, the overexpression of which is correlated with poor prognosis in various types of cancer. Antibodies inhibiting cell-cell adhesion mediated by P-cadherin show clear therapeutic effect, although the mechanistic basis explaining their effectiveness is still unclear. Based on structural, physicochemical, and functional analyses, we have elucidated the molecular mechanism of disruption of cell adhesion by antibodies targeting human P-cadherin. Herein we have studied three different antibodies, TSP5, TSP7, and TSP11, each recognizing a different epitope on the surface of the cell-adhesive domain (EC1). Although all these three antibodies recognized human P-cadherin with high affinity, only TSP7 disrupted cell adhesion. Notably, we demonstrated that TSP7 abolishes cell adhesion by disabling the so-called X-dimer (a kinetic adhesive intermediate), in addition to disrupting the strand-swap dimer (the final thermodynamic state). The inhibition of the X-dimer was crucial for the overall inhibitory effect, raising the therapeutic value of a kinetic intermediary not only for preventing, but also for reversing, cell adhesion mediated by a member of the classical cadherin family. These findings should help to design more innovative and effective therapeutic solutions targeting human P-cadherin. PubMed: 28045038DOI: 10.1038/srep39518 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (2.45 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






